CHRNA7 and early-onset autosomal dominant Alzheimer disease: Since our studies suggest that α7⁎nAChRs are expressed at higher intensities on immature granule cells in the postnatal DG, one therapeutic avenue of action of specific α7⁎nAChRs agonists could therefore be via these cells in the DG and these could be a target for the treatment of Alzheimer׳s disease.